• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

ASO Author Reflections: Is Intensifying Loco-Regional Treatment in the Early Course of De Novo Stage IV Breast Cancer Reasonable?

作者信息

Soran Atilla

机构信息

Division of Surgical Oncology, Department of Surgery, University of Pittsburgh Medical Center, Magee-Womens Hospital, Pittsburgh, PA, USA.

出版信息

Ann Surg Oncol. 2018 Dec;25(Suppl 3):663-664. doi: 10.1245/s10434-018-6924-5. Epub 2018 Oct 24.

DOI:10.1245/s10434-018-6924-5
PMID:30357577
Abstract
摘要

相似文献

1
ASO Author Reflections: Is Intensifying Loco-Regional Treatment in the Early Course of De Novo Stage IV Breast Cancer Reasonable?ASO作者反思：在新发IV期乳腺癌病程早期强化局部区域治疗是否合理？
Ann Surg Oncol. 2018 Dec;25(Suppl 3):663-664. doi: 10.1245/s10434-018-6924-5. Epub 2018 Oct 24.
2
ASO Author Reflections: Effect of Primary Surgery on Quality of Life in De Novo Stage IV Breast Cancer Patients.ASO作者反思：初次手术对初诊IV期乳腺癌患者生活质量的影响
Ann Surg Oncol. 2020 Apr;27(4):1034-1035. doi: 10.1245/s10434-019-08130-z. Epub 2020 Feb 7.
3
ASO Author Reflections: Breast Cancer Local Recurrence Versus New Primary-Clinical Predictors and Prognostic Implications.美国骨科学会作者反思：乳腺癌局部复发与新发原发性癌——临床预测因素及预后意义
Ann Surg Oncol. 2018 Dec;25(Suppl 3):648-649. doi: 10.1245/s10434-018-6889-4. Epub 2018 Oct 10.
4
ASO Author Reflections: Surgical Management Should be Considered in Patients with De Novo Stage IV Inflammatory Breast Cancer.ASO作者反思：初诊IV期炎性乳腺癌患者应考虑手术治疗。
Ann Surg Oncol. 2022 Oct;29(11):6689-6690. doi: 10.1245/s10434-022-12016-y. Epub 2022 Jun 14.
5
ASO Author Reflections: The Multidisciplinary Approach to de Novo Metastatic Inflammatory Breast Cancer: A Combined Systemic and Locoregional Strategy.ASO作者反思：新发转移性炎性乳腺癌的多学科治疗方法：综合全身和局部区域策略
Ann Surg Oncol. 2021 Aug;28(8):4275-4276. doi: 10.1245/s10434-020-09421-6. Epub 2021 Jan 6.
6
Isolated loco-regional recurrence of breast cancer is more common in young patients and following breast conserving therapy: long-term results of European Organisation for Research and Treatment of Cancer studies.乳腺癌孤立性局部区域复发在年轻患者及保乳治疗后更为常见：欧洲癌症研究与治疗组织研究的长期结果
Eur J Cancer. 2006 Feb;42(3):351-6. doi: 10.1016/j.ejca.2005.10.006. Epub 2005 Nov 28.
7
Clinical outcome in women with HER2-positive de novo or recurring stage IV breast cancer receiving trastuzumab-based therapy.曲妥珠单抗为基础的治疗用于 HER2 阳性初治或复发的 IV 期乳腺癌女性的临床结局。
Breast. 2014 Feb;23(1):44-9. doi: 10.1016/j.breast.2013.10.005. Epub 2013 Nov 7.
8
Prognosis in patients diagnosed with loco-regional failure of breast cancer: 34 years longitudinal data from the Stockholm-Gotland cancer registry.局部区域复发乳腺癌患者的预后：来自斯德哥尔摩-哥德堡癌症登记处的 34 年纵向数据。
Breast Cancer Res Treat. 2018 Dec;172(3):703-712. doi: 10.1007/s10549-018-4936-2. Epub 2018 Sep 17.
9
ASO Author Reflections: Effect Sizes of Whole Breast Radiotherapy and Systemic Therapies on Regional Recurrence Incidence in Breast Cancer Patients.ASO作者反思：全乳放疗和全身治疗对乳腺癌患者区域复发率的效应大小
Ann Surg Oncol. 2020 Sep;27(9):3412-3413. doi: 10.1245/s10434-020-08434-5. Epub 2020 Apr 4.
10
Prognosis after treatment for loco-regional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM). EORTC Breast Cancer Cooperative Group and the Danish Breast Cancer Cooperative Group.两项随机试验（欧洲癌症研究与治疗组织10801试验和丹麦乳腺癌协作组-82TM试验）中乳房切除术后或保乳治疗后局部区域复发的治疗预后。欧洲癌症研究与治疗组织乳腺癌协作组和丹麦乳腺癌协作组。
Eur J Cancer. 1999 Jan;35(1):32-8. doi: 10.1016/s0959-8049(98)00301-3.